liraglutide
PrintTrade Name(s): Victoza; Saxenda | |
Group 2: Non-Antineoplastic Hazardous | AHFS Class: Incretin Mimetics |
Action | Gloves | Gown | Eye/Face | Mask | CSTD | |
Dispensing prepackaged formulations |
| |||||
Preparing an Injectable Dose | If risk of spill or splash | If risk of inhalation | If dosage form allows |
| ||
Formulation | Gloves | Gown | Eye/Face | Mask | CSTD |
Prepared injectable (vial, syringe, IV solution*, irrigation**) | or Recommended if pregnant, breast feeding, or trying to conceive | If splash possible or recommended if pregnant, breast feeding, or trying to conceive | If splash possible or recommended if pregnant, breast feeding, or trying to conceive | Recommended if pregnant, breast feeding, or trying to conceive | If dosage form allows |
Manufacturer packaged pre-filled syringe or injector | or Recommended if pregnant, breast feeding, or trying to conceive | if provided in kit, or if dosage form allows |
* Intravenous tubing already attached and primed.
** Bladder, HIPEC, limb perfusion, etc.
Reference: NIOSH 2016, USP <800>
Type of Instance | Gloves | Gown | Mask | Eye/Face | Notes/Instructions |
Receiving undamaged HD shipping container |
| ||||
Receiving damaged HD shipping container | If container must be opened | If container must be opened | If container must be opened |
| |
Spill Cleanup | Large volume | Large volume |
|
Reference: USP <800>
Hazardous Pharmaceutical | Trace Chemo | Biohazardous and Sharps |
1. Non-returnable hazardous, chemo and EPA regulated drugs. (Patient specific prescriptions, partially used blister packs, containers with more than 3% medication remaining) 2. Empty bottles or packaging of P-Listed drugs. (Warfarin, nicotine, epinephrine, nitroglycerin, physostigmine) 3. PPE with visible contamination from hazardous drug. | 1. Waste contaminated through contact with chemotherapeutic agents. (Empty vials, IV bags, syringes and tubing) 2. PPE worn while handling hazardous drugs with NO visible contamination. (Gowns, gloves and masks) 3. Used CSTD devices. | 1. All sharps capable of cutting or piercing the skin. (Needles/syringes, broken ampules, lancets) 2. Items contaminated with blood or other potentially infectious materials. (Tubing, bags or dressings containing blood, contaminated waste from isolation patients) |
Dosage Form | Ship to Institution or Pharmacy | Ship to Locations Outside of ODOC |
Tablets and Capsules |
|
|
Liquid, Topical, and Transdermal |
|
|
PPE | Standards |
Shoe Covers |
|
Gowns |
|
Gloves |
|
Face Shields |
|
Goggles |
|
N95 Masks |
|
Removal and Disposal |
|
Reference: USP <800>
- Suspected of causing cancer.
- Suspected of damaging fertility or the unborn child
Reference: SDS - Cayman Chemical
Black Box warning for thyroid C-cell tumors, with supporting evidence in laboratory studies; In laboratory studies, teratogenic at or below the MRHD
Liraglutide is an acylated synthetic glucagon-like peptide-1 analogLabel,1,2. Liraglutide is an agonist of the glucagon-like peptide-1 receptor which is coupled to adenylate cyclaseLabel. The increase in cyclic AMP stimulates the glucose dependant release of insulin, inhibits the glucose dependant release of glucagon, and slows gastric emptying to increase control of blood sugarLabel,3.
Reference: Drug Bank